-
Ovid Therapeutics Inc. (NASDAQ:OVID) Receives Consensus Rating of "Moderate Buy" from Analysts
Source: Buzz FX / 23 Nov 2024 05:02:10 America/New_York
Ovid Therapeutics Inc. (NASDAQ:OVID) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Ovid Therapeutics Inc. ( NASDAQ:OVID - Get Free Report ) has been assigne
Read more...